Dianrong is a leading online marketplace connecting millions of borrowers and lenders from China.

Charles Russell Speechlys have recently advised Chelverton Small Companies Dividend Trust PLC (Chelverton) on a combined main market issue of C shares (by way of an offer for subscription, intermediaries offer and placing) and zero dividend preference shares by a newly incorporated subsidiary of Chelverton, together with a “rollover” of existing zero dividend preference shares via a s. 110 Insolvency Act 1986 scheme of reconstruction.

Charles Russell Speechlys has advised Business Growth Fund (BGF) on its investment in Revital, a London based multi-channel retailer of supplements, beauty and wellness products.

Hill Dickinson has recently advised AIM-listed client BMR Group Plc (BMR) on the acquisition of 29.01% interest in the enlarged share capital of BMR by Jubilee Metals Group Plc (Jubilee) to advance the BMR’s Kabwe zinc-lead project in Zambia.

Osborne Clarke has advised Acellere GmbH, on the closing of its series A EUR 2.25 million financing round. The investment comes from Capnamic Ventures and several business angels.

The Frankfurt-based start-up has created “Gamma”, a software analytics platform to assist developers in identifying and mitigating bugs and structural issues in software code. It’s used by companies in the finance, automotive and energy sectors.

Hill Dickinson is pleased to announce that its client Juvenescence Limited (Juvenescence), a British Virgin Islands-based holding company that invests in human ageing and longevity, has closed its series seed fundraising.

We have advised longstanding client Piper, the UK's leading specialist investor in consumer brands, on its growth capital investment into beauty and wellbeing brand Neom Organics.

Macfarlanes has advised longstanding client Alchemy on the raising of its fourth special opportunities fund which, after an efficient fundraising period, has closed at its hard cap of £900m.

The successful fundraising drew on capital from both existing investors and a select number of new investors, primarily from the US and Europe. 

Shearman & Sterling advised HalioDx, a diagnostic company expert in immuno-oncology, on the closing of an €18.5 million Series B financing after a Series A round of €8 million in March 2015.

The latest round was led by Bpifrance’s PSIM fund, which was joined by Capricorn Venture Partners and Amundi Private Equity Funds. The fundraising will accelerate the development of HalioDx’s Immunoscore platform for colon cancer and other types of cancer and allow the company to set up commercial activities in the U.S.

Simpson Thacher represented BC Partners in connection with the raising of BC European Capital X ("BCEC X"), BC Partners' tenth flagship private equity fund, which has announced a final close at its €7 billion target. Like its €6.7 billion predecessor fund, BCEC X will focus on making large, market-leading investments in Europe and, selectively, North America.